期刊文献+

成人髓母细胞瘤不同病理亚型临床特征及预后分析 被引量:10

Analysis of pathologic characteristics and prognosis in different subtypes of adult medulloblastoma
原文传递
导出
摘要 目的探讨成人髓母细胞瘤(MB)不同病理学亚型的临床特点及预后。方法回顾性分析2000年6月至2012年6月151例成人MB的临床资料、影像学和病理学表现,采用x^2检验对各亚型临床特征进行分析,Kaplan—Meier生存分析对各亚型生存期进行比较。结果151例MB包括经典型73例,促纤维增生/结节型36例,间变型39例,大细胞型3例;其中促纤维增生/结节型较其他亚型更常见于小脑半球(P=0.000),间变型和大细胞型较其他亚型更容易复发(P=0.000)及转移(P=0.003);至随访期结束无瘤生存患者91例,带瘤生存15例,死亡45例,生存时间为6~150个月,平均生存时间(103.3±5.7)个月(95%CI92.52—115.09);其中经典型组、促纤维增生/结节型组、问变型和大细胞型组平均生存期分别为(110.7±7.8)、(125.5±7.6)和(57.6±7.6)个月,差异具有统计学意义(P=0.000)。结论成人MB各个病理亚型具有不同临床特点,而间变型和大细胞型成人MB患者预后不良。 Objective To study the pathologic characteristics and prognosis in different subtypes of adult medulloblastoma (MB). Methods The clinical information, imaging findings and pathologic characteristics of 151 cases of adult medulloblastomas were retrospectively reviewed and analyzed by chi-square test. The survival data were assessed using the Kaplan-Meier method. Results Amongst the 151 MB cases studied, there were 73 cases of classic MB, 36 cases of desmoplastic/nodular MB, 39 cases of anaplastic MB and 3 cases of large cell MB. The primary tumors were more frequently located in cerebral hemisphere in desmoplastic/nodular MB than in other subtypes (P = 0. 000). On the other hand, large cell/ anaplastic MB were associated with more frequently local recurrence and distant metastasis (P = 0. 003). The post-operative overall survival time ranged from 6 to 150 months, with median survival being ( 103.3 ±5.7) months (95% CI, 92. 52 to 115.09). The median survival of classic MB, desmoplastic/nodular MB and large cell/anaplastic MB was (110.7 ±7.8) months, (125.5 ±7.6) months and (57.6 ±7.6 ) months, respectively. The differences were statistically significant ( P = 0. 000 ). Conclusions The three variants of MB show different biologic behavior. Large cell/anaplastic MB represents an independent poor prognostic indicator in adults.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2014年第3期169-172,共4页 Chinese Journal of Pathology
基金 国家科技支撑计划(2012BA112803) 首都卫生发展科研专项项目(首发2011-1015-01) 北京市卫生系统高层次卫生技术人才队伍建设专项经费(2011-03-027)
关键词 髓母细胞瘤 年龄分布 肿瘤 组织学类型 预后 Medulloblastoma Age distribution Neoplasms by histologie type Prognosis
  • 相关文献

参考文献17

  • 1Louis DN,Ohgaki H,Wiestler OD,et al.WHO classification of tumours of the central nervous system[M].Lyon:IARC Press,2007:132-140.
  • 2Silvani A,Gaviani P,Lamperti E,et al.Adult medulloblastoma:multiagent chemotherapy with cisplatinum and etoposide:a singleinstitutional experience[J].J Neurooncol,2012,106 (3):595-600.
  • 3李南云,朱加明,马恒辉,孙桂勤,严小娟,郭慧芳.成人小脑髓母细胞瘤的临床及病理研究[J].中华病理学杂志,1998,27(3):213-215. 被引量:8
  • 4Eberhart CG,Kepner JL,Goldthwaite PT,et al.Histopathologic grading of medulloblastomas:a Pediatric Oncology Group study[J].Cancer,2002,94(2):552-560.
  • 5Northcott PA,Shih DJ,Peacock J,et al.Subgroup-specific structural variation across 1,000 medulloblastoma genomes[J].Nature,2012,488 (7409):49-56.
  • 6赵赋,张玉琪,王振民,王小平,杨智君,罗麟,FeliceGiangaspero,刘丕楠.促纤维增生/结节型髓母细胞瘤病理学特点及相关信号通路研究[J].中华神经外科杂志,2012,28(10):1040-1044. 被引量:4
  • 7Northcott PA,Shih D J,Remke M,et al.Rapid,reliable,and reproducible molecular sub-grouping of clinical medulloblastoma samples[J].Acta Neuropathol,2012,123(4):615-626.
  • 8von Hoff K,Hartmann W,von Bueren AO,et al.Large cell/ anaplastic medulloblastoma:outcome according to myc status,histopathological,and clinical risk factors[J].Pediatr Blood Cancer,2010,54(3):369-376.
  • 9Rodriguez FJ,Eberhart C,O' Neill BP,et al.Histopathologic grading of adult medulloblastomas[J].Cancer,2007,109 (12):2557-2565.
  • 10赵赋,渠沛然,张晶,王振民,王兴朝,杨智君,刘丕楠.成人髓母细胞瘤的临床治疗及预后分析[J].中华神经科杂志,2013,46(7):470-473. 被引量:9

二级参考文献49

共引文献23

同被引文献87

  • 1周芹,孙军燕,孙富先,李传亭.MRI常规扫描结合DWI对髓母细胞瘤的诊断价值[J].医学影像学杂志,2005,15(2):100-103. 被引量:7
  • 2施裕新,徐建峰.CT灌注成像对脑肿瘤瘤周水肿的评价[J].中华放射学杂志,2005,39(5):469-471. 被引量:19
  • 3靳松,崔世民,刘梅丽,戴伟英,高满,田超,杨天昊.幕上原始神经外胚层肿瘤的CT、MRI和病理分析[J].临床放射学杂志,2006,25(8):707-710. 被引量:24
  • 4杨柳松,黄峰平.小脑半球髓母细胞瘤的诊断和治疗[J].中华神经外科疾病研究杂志,2007,6(4):327-329. 被引量:4
  • 5Po|kinghom WR, Tarbell NJ. Medu|loblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification [ J 1. Nat Clin Praet Oneo1,2007,4 (5) :295-304.
  • 6Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO ~lassification of tumours of the central nervous system [ J ~. Aeta Neuropathol, 2007,114 ( 2 ) : 97 -109. DOI : 10.1007/s00401-007 -0243 -4.
  • 7Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants [ J ]. J Clin Oncol, 2011,29 ( 11 ) : 1408-1414. DOI : 10. 1200/JCO. 2009.27. 4324.
  • 8Ellison DW, Dalton J, Koeak M, et al. Medulloblastoma : clinico- pathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups [ J ]. Acta Nenropathologica, 2011 , 21 ( 3 ) : 381-396. DOI : 10. 1007/s00401-011-0800-8.
  • 9Lai R. Survival of patients with adult medulloblastoma: a population-based study[ J]. Cancer, 2008,112 ( 7 ) : 1568-1574. DOI : 10. 1002/cncr. 23329.
  • 10Ellison DW, Kocak M, Dalton J, et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables [ J ]. 2011,29 ( 11 ) : 1400-1407. DOI : 10. 1200/JCO. 2010.30.2810.

引证文献10

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部